T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Brixmor Property Group
BRX
$9.21B
| $884K | ﹤0.01% |
93,102
+390
| +0.4% | +$6.99K |
|
|
HHR
1752
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $884K | ﹤0.01% |
55,367
| – | – |
|
1753
HUB Group
HUBG
$2.55B
| $883K | ﹤0.01% |
38,834
+5,214
| +16% | +$131K |
|
|
KEM
1754
DELISTED
KEMET Corporation
KEM
| $883K | ﹤0.01% |
36,536
-30,536
| -46% | -$775K |
|
1755
Genworth Financial
GNW
$3.77B
| $879K | ﹤0.01% |
264,637
-63,357
| -19% | -$263K |
|
1756
CONMED
CNMD
$1.49B
| $878K | ﹤0.01% |
15,339
+170
| +1% | +$15.7K |
|
1757
Avis
CAR
$4.84B
| $877K | ﹤0.01% |
63,105
+17,571
| +39% | +$526K |
|
1758
EXL Service
EXLS
$5.36B
| $874K | ﹤0.01% |
83,945
+5,370
| +7% | +$73.2K |
|
1759
Coca-Cola Europacific Partners
CCEP
$47.5B
| $869K | ﹤0.01% |
23,168
+4,237
| +22% | +$206K |
|
|
IBKC
1760
DELISTED
IBERIABANK Corp
IBKC
| $868K | ﹤0.01% |
24,010
+311
| +1% | +$19.4K |
|
1761
Lithia Motors
LAD
$8.32B
| $863K | ﹤0.01% |
10,546
+131
| +1% | +$15.8K |
|
1762
First Financial Bancorp
FFBC
$3.6B
| $862K | ﹤0.01% |
57,833
+3,810
| +7% | +$81.8K |
|
1763
Four Corners Property Trust
FCPT
$2.76B
| $860K | ﹤0.01% |
45,963
-18,032
| -28% | -$487K |
|
|
AGTC
1764
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $860K | ﹤0.01% |
262,055
| – | – |
|
|
SRG
1765
Seritage Growth Properties
SRG
$128M
| $858K | ﹤0.01% |
94,189
+26,362
| +39% | +$822K |
|
|
ESGR
1766
DELISTED
Enstar Group
ESGR
| $857K | ﹤0.01% |
5,391
+65
| +1% | +$11.9K |
|
|
CADE
1767
DELISTED
Cadence Bank
CADE
| $856K | ﹤0.01% |
45,233
+6,305
| +16% | +$167K |
|
1768
CareCloud
CCLD
$104M
| $856K | ﹤0.01% |
155,600
+11,500
| +8% | +$60.2K |
|
1769
Hancock Whitney
HWC
$6.37B
| $852K | ﹤0.01% |
43,656
+8,620
| +25% | +$298K |
|
|
PRO
1770
DELISTED
PROS Holdings
PRO
| $851K | ﹤0.01% |
27,414
-1,162
| -4% | -$58.1K |
|
|
AEL
1771
DELISTED
American Equity Investment Life Holding Company
AEL
| $848K | ﹤0.01% |
45,100
+10,610
| +31% | +$271K |
|
1772
Fox Factory Holding Corp
FOXF
$886M
| $847K | ﹤0.01% |
20,169
+995
| +5% | +$62.8K |
|
1773
Healthcare Services Group
HCSG
$1.45B
| $842K | ﹤0.01% |
35,197
+2,600
| +8% | +$66.8K |
|
|
ECHO
1774
EchoStar
ECHO
$26.6B
| $841K | ﹤0.01% |
26,301
+3,640
| +16% | +$136K |
|
1775
ZTO Express
ZTO
$17.4B
| $840K | ﹤0.01% |
31,709
+3,052
| +11% | +$74K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.